Webinar Recording: Immunogenicity assessment of gene therapy compounds: discussion on current and future concepts

After a series of setbacks in the nineties, several gene therapies have now been approved by health agencies worldwide. As a consequence, the number of these compounds in development has literally exploded during recent years.

However, safety and efficacy concerns remain and the unwanted cellular and humoral responses to these compounds need to be controlled and assessed. This webinar will be a discussion on concepts and challenges of immunogenicity testing for gene therapies.